default author photo

Nicolas Girard

PSL Research University - Institut Curie

SCHOLARLY PAPERS

3

DOWNLOADS

108

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Lung cancer epidemiology in France: rising the Epidemiological Strategy and Medical Economics (ESME) Lung Cancer database Lung cancer in France

Number of pages: 32 Posted: 09 Mar 2026
Nicolas Girard, Matthieu Carton, Pauline MACOUILLARD, Didier Debieuvre, Xavier QUANTIN, Clarisse Audigier-Valette, herve Lena, Thomas Filleron, Radj Gervais, Roland Schott, Jordi Remon, Grégoire JUSTEAU, Lise Bosquer, Anne-Laure Martin, Christos Chouaïd and Maurice Perol
PSL Research University - Institut Curie, PSL Research University - Institut Curie, UNICANCER, affiliation not provided to SSRN, affiliation not provided to SSRN, CHITS Sainte Musse, CHU Rennes, Institut Claudius Regaud, affiliation not provided to SSRN, Institut de cancérologie Strasbourg Europe ICANS, Gustave Roussy, University of Angers - CHU Angers, UNICANCER, UNICANCER, Centre Hospitalier Intercommunal de Créteil and University of Claude Bernard Lyon 1 - Centre Léon Bérard
Downloads 45 (1,157,785)

Abstract:

Loading...

Real-world data, real-life, patient medical record, quality control, Lung cancer

2.

Palliative Care Integration and End-of-Life Care Intensity for Patients with Nsclc

Number of pages: 16 Posted: 11 Jan 2024
Alice Martin, Matthieu Carton, Laura Thery, Alexis Burnod, Catherine Daniel, Pauline du Rusquec, Nicolas Girard and Carole Bouleuc
PSL Research University - Institut Curie, PSL Research University - Institut Curie, PSL Research University - Institut Curie, PSL Research University - Institut Curie, PSL Research University - Institut Curie, Institut Curie - Department of Drug Development and Innovation (D3i), PSL Research University - Institut Curie and PSL Research University - Institut Curie
Downloads 39 (1,196,171)

Abstract:

Loading...

metastatic non-small cell lung cancer, end-of-life care, palliative care, systemic cancer treatment discontinuation

3.

The TIGOS Trial: A Randomized, Double-Blind, Phase III Trial of Atigotatug and Nivolumab Fixed-Dose Combination With Chemotherapy Versus Atezolizumab With Chemotherapy as First-Line Therapy in Patients With Extensive-Stage Small Cell Lung Cancer

Number of pages: 30 Posted: 24 Nov 2025
Neal E. Ready, Luis Paz Ares, Kenneth O'Byrne, Melissa Johnson, Martin Reck, Nicolas Girard, Hidetoshi Hayashi, Caicun Zhou, Vishwanath Suresh Gharpure, Radhika Pisupati and Misena Pacius
Duke University - Duke Cancer Institute, University Hospital 12 de Octubre, Queensland University of Technology, Sarah Cannon Research Institute, German Centre for Lung Research - Lungen Clinic Grosshansdorf, PSL Research University - Institut Curie, Kindai University, Tongji University - Department of Medical Oncology, Bristol Myers Squibb, Bristol Myers Squibb and Bristol Myers Squibb
Downloads 24 (1,399,036)

Abstract:

Loading...

Nivolumab, atigotatug, extensive-stage small cell lung cancer, innate immune inducer, Fuc-GM1